Parasitic infections in hematopoietic stem cell transplant recipients.
HSCT
parasitic infections
transplant recipients
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
24
08
2023
accepted:
16
09
2023
medline:
11
12
2023
pubmed:
4
10
2023
entrez:
4
10
2023
Statut:
ppublish
Résumé
Hematopoietic stem cell transplantation (HSCT) is a vital treatment for various hematological disorders. However, HSCT recipients face increased risks of infectious complications due to immunosuppression. Parasitic infections are a significant concern in this vulnerable population and can lead to substantial morbidity and mortality. This review examines parasitic infections in HSCT recipients, focusing on major infections affecting different organ systems, including intestinal parasites (Giardia spp., Entamoeba histolytica, and Cryptosporidium spp.), hematologic parasites (Plasmodium spp. and Babesia spp.), and tissue/visceral parasites (Toxoplasma gondii, Leishmania spp., and Trypanosoma cruzi). A systematic search of relevant literature was conducted and included studies up to August 2023. Databases included PubMed, Google Scholar, were queried using specific keywords related to parasitic infections in HSCT patients. The epidemiology, risk factors, clinical presentation, diagnostic methods, and treatment approaches for each infection were evaluated. Knowing the epidemiology, risk factors, and clinical presentations are crucial for timely intervention and successful management. By emphasizing early detection, effective therapies, and the unique challenges posed by each of these infections, this review highlights the importance of tailored strategies for HSCT recipients. Future research can further refine management protocols to enhance care and outcomes for these patients.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14160Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Muhsen IN, Galeano S, Niederwieser D, et al. Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: A Worldwide Network for Blood and Marrow Transplantation (WBMT) Review. Lancet Haematol. 2023;10(4):e295-e305.
Rubin RH. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities. Clin Transplant. 2001;15(4):11-22.
Bowden RA. Transplant Infections. Wolters Kluwer; 2015.
Feng Y, Xiao L. Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin Microbiol Rev. 2011;24(1):110-140.
Dixon BR. Giardia duodenalis in humans and animals-Transmission and disease. Res Vet Sci. 2021;135:283-289.
Guerrant RL, Walker DH, Weller PF. Tropical Infectious Diseases: Principles, Pathogens and Practice E-Book: Tropical Infectious Diseases: Principles, Pathogens and Practice E-Book. Elsevier Health Sciences; 2011.
Nash TE, Herrington DA, Losonsky GA, Levine MM. Experimental human infections with Giardia lamblia. J Infect Dis. 1987;156(6):974-984.
Ma S, Yan H, Shi W, You Y, Zhong Z-D, Hu Yu. Giardia lamblia mimicking acute graft versus host disease after allogeneic hematopoietic stem cell transplantation: A case report. Medicine. 2020;99(33):e21752.
Ajumobi AB, Daniels JA, Sostre CF, Trevino HH. Giardiasis in a hematopoietic stem cell transplant patient. Transpl Infect Dis. 2014;16(6):984-987.
Bromiker R, Or R, Hardan I, Naparstek E, Engelhard D. Severe giardiasis in two patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1989;4(6):701-703.
Kang G, Srivastava A, Pulimood AB, Dennison D, Chandy M. Etiology of diarrhea in patients undergoing allogeneic bone marrow transplantation in South India. Transplantation. 2002;73(8):1247-1251.
Faubert G. Immune response to Giardia duodenalis. Clin Microbiol Rev. 2000;13(1):35-54.
Blakey JL, Barnes GL, Bishop RF, Ekert H. Infectious diarrhea in children undergoing bone-marrow transplantation. Aust NZ J Med. 1989;19(1):31-36.
Silva RKNR, Pacheco FTF, Martins AS, et al. Performance of microscopy and ELISA for diagnosing Giardia duodenalis infection in different pediatric groups. Parasitol Int. 2016;65(6):635-640.
Aronson NE, Cheney C, Rholl V, Burris D, Hadro N. Biliary giardiasis in a patient with human immunodeficiency virus. J Clin Gastroenterol. 2001;33(2):167-170.
Fabiani S, Fortunato S, Bruschi F. Solid organ transplant and parasitic diseases: A review of the clinical cases in the last two decades. Pathogens. 2018;7(3):65.
Nooshadokht M, Kalantari-Khandani B, Sharifi I, et al. Stool antigen immunodetection for diagnosis of Giardia duodenalis infection in human subjects with HIV and cancer. J Microbiol Methods. 2017;141:35-41.
Radisic MV, Linares L. Parasites After Hematopoietic Stem Cell or Solid Organ Transplantation, in Transplant Infections: Fourth Edition. Springer International Publishing; 2016.
Ghosh S, Padalia J, Moonah S. Tissue destruction caused by Entamoeba histolytica parasite: Cell death, inflammation, invasion, and the gut microbiome. Curr Clin Microbiol Rep. 2019;6(1):51-57.
Stauffer W, Ravdin JI. Entamoeba histolytica: An update. Curr Opin Infect Dis. 2003;16(5):479-485.
Numata A, Itabashi M, Kishimoto K, et al. Intestinal amoebiasis in a patient with acute graft-versus-host disease after allogeneic bone marrow transplantation successfully treated by metronidazole. Transpl Infect Dis. 2015;17(6):886-889.
Bavaro P. Amebiasis after bone marrow transplantation. Bone Marrow Transplant. 1994;13(2):213-214.
Perret C, Harris PR, Rivera M, Vial P, Duarte I, Barriga F. Refractory enteric amebiasis in pediatric patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Pediatr Gastroenterol Nutr. 2000;31(1):86-90.
Ruiz-Argüelles G. Amoebic paralytic ileus in a patient given an autologous stem cell transplantation. HAEMA. 2006;9:431-432.
Bercu TE, Petri WA, Behm BW. Amebic colitis: New insights into pathogenesis and treatment. Curr Gastroenterol Rep. 2007;9(5):429-433.
Martín-Dávila P, Fortún J, López-Vélez R, et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev. 2008;21(1):60-96.
Hal SJ, Stark DJ, Fotedar R, Marriott D, Ellis JT, Harkness JL, Amoebiasis: current status in Australia. Med J Aust. 2007;186(8):412-416.
Haque R, Huston CD, Hughes M, Houpt E, Petri WA. Amebiasis. N Engl J Med. 2003;348(16):1565-1573.
Abasszade JH, Little R, Yeaman F, Robertson M, Bell S. Amoebic colitis: A case series of a recurring missed diagnosis. JGH Open. 2021;5(3):404-407.
Lowther SA, Dworkin MS, Hanson DL. Entamoeba histolytica/Entamoeba dispar infections in human immunodeficiency virus-infected patients in the United States. Clin Infect Dis. 2000;30(6):955-959.
Yap FB-B, Lee BR. Erythema Nodosum-Like lesions in a renal transplant recipient-Quiz case. Arch Dermatol. 2011;147(6):735-740.
Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J. Laboratory Diagnostic Techniques for Entamoeba Species. Clin Microbiol Rev . 2007;20(3):511-532.
Roure S, Valerio L, Soldevila L, et al. Approach to amoebic colitis: Epidemiological, clinical and diagnostic considerations in a non-endemic context (Barcelona, 2007-2017). PLoS One. 2019;14(2):e0212791.
Schwartz BS, Mawhorter SD. Parasitic infections in solid organ transplantation. Am J Transplant. 2013;13(s4):280-303.
Dong S, Yang Y, Wang Y, et al. Prevalence of cryptosporidium infection in the global population: A systematic review and meta-analysis. Acta Parasitol, 2020;65(4):882-889.
Abubakar II, Aliyu SH, Arumugam C, Hunter PR, Usman N. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev. 2007;(1):Cd004932.
Van Kraaij M, Dekker Aw, Verdonck Lf, et al. Infectious gastro-enteritis: An uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant. 2000;26(3):299-303.
Legrand F, Grenouillet F, Larosa F, Dalle F, Saas P, Millon L, Deconinck E, Rohrlich PS Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: A prospective single centre study. Bone Marrow Transplant. 2011;46(6):858-862.
Müller CI, Zeiser R, Grullich C, et al. Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation. Transplantation. 2004;77(9):1478-1479.
Kagawa K, Fujino H, Miki H, et al. Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of Cryptosporidium oocysts by intestinal biopsies. Transpl Infect Dis. 2018;20(2):e12826.
Schiller J, Klein S, Engels M, et al. Case Report: A Cryptosporidium infection in a patient with relapsed T-lymphoblastic lymphoma undergoing allogeneic stem cell transplantation. Eur J Haematol. 2018;100(4):383-385.
Sebastián E, Martín J, Mcdonald GB, et al. Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: Diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant. 2011;46(4):612-614.
Gerace E, Presti VD, Biondo C. Cryptosporidiuminfection: epidemiology, pathogenesis, and differential diagnosis. Eur J Microbiol Immunol. 2019;9(4):119-123.
Filosso PL, Galassi C, Ruffini E, et al. Thymoma and the increased risk of developing extrathymic malignancies: A multicentre study†. Eur J Cardio Thoracic Surg. 2013;44(2):219-224.
Van Lint P, Rossen J, Vermeiren S, et al. Detection of Giardia lamblia, Cryptosporidium spp. and Entamoeba histolytica in clinical stool samples by using multiplex real-time PCR after automated DNA isolation. Acta Clin Belg. 2013;68(3):188-192.
Florescu DF, Sandkovsky U. Cryptosporidium infection in solid organ transplantation. World J Transplant. 2016;6(3):460-471.
Khan SM, Witola WH. Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: A comprehensive review. Front Cell Infect Microbiol. 2023;13:1115522.
Amadi B, Mwiya M, Sianongo S, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: A randomised controlled trial. BMC Infect Dis. 2009;9(1):195.
Tomczak E, Mcdougal AN, White AC. Resolution of Cryptosporidiosis in transplant recipients: Review of the literature and presentation of a renal transplant patient treated with nitazoxanide, azithromycin, and rifaximin. Open Forum Infect Dis. 2021;9(1):ofab610.
Faraci M, Cappelli B, Morreale G, et al. Nitazoxanide or CD3+/CD4+ lymphocytes for recovery from severe Cryptosporidium infection after allogeneic bone marrow transplant? Pediatr Transplant. 2007;11(1):113-116.
Nachbaur D, Kropshofer G, Feichtinger H, Allerberger F, Niederwieser D. Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2. Bone Marrow Transplant. 1997;19(12):1261-1263.
Menon VG, Elias N. Parasitic Infections in the Immunocompromised Host: Prevention, Diagnosis, and Management. in: G. Tsoulfas, Hoballah JJ, Velmahos GC, Ho Y-K, eds. The Surgical Management of Parasitic Diseases. Springer International Publishing; 2020:323-339.
Monroe A, Williams NA, Ogoma S, Karema C, Okumu F. Reflections on the 2021 World Malaria Report and the future of malaria control. Malar J. 2022;21(1):154.
Jarque I, Salavert M, Pemán J. Parasitic infections in hematopoietic stem cell transplantation. Mediterr J Hematol Infect Dis. 2016;8:2116035.
Inoue J, Machado CM, Lima GFMDC, Nascimento MDJC, Colturato VR, Di Santi SM. The monitoring of hematopoietic stem cell transplant donors and recipients from endemic areas for malaria. Revista do Instituto de Medicina Tropical de São Paulo. 2010;52(5):281-284.
Raina V, Sharma A, Gujral S, Kumar R. Plasmodium vivax causing pancytopenia after allogeneic blood stem cell transplantation in CML. Bone Marrow Transplant. 1998;22(2):205-206.
Salutari P, Sica S, Chiusolo P, Antinori A, Leone G. Plasmodium vivax malaria after autologous bone marrow transplantation: An unusual complication. Bone Marrow Transplant. 1996;18(4):805-806.
Dharmaseva F, Gordon-Smith EC. Transmission of malaria by bone marrow transplantation. Transplantation. 1986;42(2):228.
Lefrère F, Besson C, Datry A, et al. Transmission of Plasmodium falciparum by allogeneic bone marrow transplantation. Bone Marrow Transplant. 1996;18(2):473-474.
Tran V-B, Tran V-B, Lin K-H. Malaria infection after allogeneic bone marrow transplantation in a child with thalassemia. Bone Marrow Transplant. 1997;19(12):1259-1260.
O'donnell J, Goldman J, Wagner K, et al. Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantation. Bone Marrow Transplant. 1998;21(3):313-314.
Villeneuve L, Cassaing S, Magnaval J-F, et al. Plasmodium falciparum infection following allogeneic bone-marrow transplantation. Ann Trop Med Parasitol. 1999;93(5):533-535.
Mejia R, Booth GS, Fedorko DP, et al. Peripheral blood stem cell transplant-related Plasmodium falciparum infection in a patient with sickle cell disease. Transfusion. 2012;52(12):2677-2682.
Abdelkefi A, Ben Othman T, Torjman L, et al. Plasmodium falciparum causing hemophagocytic syndrome after allogeneic blood stem cell transplantation. Hematol J. 2004;5(5):449-450.
Ladeb S, Ben Abdejlil N, Fakhfakh N, et al. Plasmodium falciparum infection transmitted by transfusion: A cause of hemophagocytic syndrome after bone marrow transplantation in a non-endemic country. Transpl Infect Dis. 2018;20(3):e12887.
La HRM, Morris MI. Transplantation, Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13546.
Peixoto D, Prestes DP. Parasitic infections of the stem cell transplant recipient and the hematologic malignancy patient, including toxoplasmosis and strongyloidiasis. Infect Dis Clin North Am. 2019;33(2):567-591.
Cheaveau J, Marasinghe D, Akakpo S, Deardon R, Naugler C, Chin A, Pillai DR. The impact of malaria on liver enzymes: A retrospective cohort study (2010-2017).Open Forum Infect Dis. 2019;6(6):ofz234.
Cirino CM, Leitman SF, Williams E, et al. Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease. Ann Intern Med. 2008;148(10):794.
Lubin AS, Snydman DR, Miller KB. Persistent babesiosis in a stem cell transplant recipient. Leuk Res. 2011;35(6):e77-e78.
Bade NA, Yared JA. Unexpected babesiosis in a patient with worsening anemia after allogeneic hematopoietic stem cell transplantation. Blood. 2016;128(7):1019.
Rosenblatt J, Leung A, Baneman E, et al. Relapsed Babesia microti infection following allogeneic hematopoietic cell transplantation in a patient with b-cell acute lymphoblastic leukemia: Case report and review of the literature. Open Forum Infect Dis. 2021;8(9):ofab323.
Alhomoud M, Soave R, Kluk MJ, Shore T, Acute hemolytic anemia after hematopoietic stem cell transplantation: An unusual invader. Am J Hematol. 2023;98(8):1341-1342.
Moniuszko-Malinowska A, Swiecicka I, Dunaj J, et al. Infection with Babesia microti in humans with non-specific symptoms in North East Poland. Infect Dis. 2016;48(7):537-543.
Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: Review of 34 cases and their complications. Clin Infect Dis. 2001;32(8):1117-1125.
Slovut DP, Benedetti E, Matas AJ. Babesiosis and hemophagocytic syndrome in an asplenic renal transplant recipient. Transplantation. 1996;62(4):537-539.
Perdrizet GA, Olson NH, Krause PJ, Banever GT, Spielman A, Cable RG. Babesiosis in a renal transplant recipient acquired through blood transfusion. Transplantation. 2000;70(1):205-208.
Bigna JJ, Tochie JN, Tounouga DN, et al. Global, regional, and country seroprevalence of Toxoplasma gondii in pregnant women: A systematic review, modelling and meta-analysis. Sci Rep. 2020;10(1):12102.
Goebel WS, Conway JH, Faught P, Vakili ST, Haut PR Disseminated toxoplasmosis resulting in graft failure in a cord blood stem cell transplant recipient. Pediatr Blood Cancer. 2007;48(2):222-226.
Schwenk HT, Khan A, Kohlman K, et al. Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients. Transplant Cell Ther. 2021;27(4):292-300.
Brenier-Pinchart MP, Garban F, Fricker-Hidalgo H, et al. Avoidance of Toxoplasma gondii transmission from a recently infected donor to the recipient of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005;35(7):735-736.
Robin C, Leclerc M, Angebault C, et al. Toxoplasmosis as an early complication of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2019;25(12):2510-2513.
Martino R, Bretagne S, Rovira M, et al. Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2000;25(10):1111-1114.
Gajurel K, Dhakal R, Montoya JG. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: A review of the literature and recommendations. Curr Opin Infect Dis. 2015;28(4):283-292.
Chandrasekar P, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team Bone Marrow Transplant. 1997;19(7):685-689.
Contopoulos-Ioannidis DG, Cho SM, Bertaina A, et al. Toxoplasmosis among 38 751 Hematopoietic stem-cell transplant recipients: A systematic review of disease prevalence and a compilation of imaging and autopsy findings. Transplantation. 2021;105(12):e375-e386.
Adekunle RO, Sherman A, Spicer JO, et al. Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers. Transpl Infect Dis. 2021;23(4):e13636.
Mele A, Paterson P, Prentice H, Leoni P, Kibbler C. Toxoplasmosis in bone marrow transplantation: A report of two cases and systematic review of the literature. Bone Marrow Transplant. 2002;29(8):691-698.
Štajner T, Vujić D, Srbljanović J, et al. Risk of reactivated toxoplasmosis in haematopoietic stem cell transplant recipients: A prospective cohort study in a setting withholding prophylaxis. Clin Microbiol Infect.2022;28(5):733.e1-733.e5.
Rauwolf KK, Floeth M, Kerl K, Schaumburg F, Groll AH. Toxoplasmosis after allogeneic haematopoietic cell transplantation-disease burden and approaches to diagnosis, prevention and management in adults and children. Clin Microbiol Infect. 2021;27(3):378-388.
Conrad A, Le Maréchal M, Dupont D, et al. A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication. Clin Microbiol Infect. 2016;22(7):636-641.
Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14(12):1089-1101.
Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant. 2009;44(8):453-455.
Paccoud O, Guitard J, Labopin M, et al. Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting. Bone Marrow Transplant. 2020;55(1):93-99.
Robert-Gangneux F, Meroni V, Dupont D, et al. Toxoplasmosis in Transplant Recipients, Europe, 2010-2014. Emerg Infect Dis. 2018;24(8):1497-1504.
Palmisano G, Yoshida N, Editorial: World Chagas disease day 2022. Front Cell Infect Microbiol. 2023;13:1209531.
Rojas JD, Martinez BMP, Gomez JC, Cuervo SI. Disease Chagas. Ann Intern Med. 2023;176(2):ITC17-ITC32.
Pinazo M-J, Miranda B, Rodríguez-Villar C, et al. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev. 2011;25(3):91-101.
Villalba R, Fornes G, Alvarez MA, et al. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: Case report. Clin. Infect. Dis. 1992;14(2):594-595.
Altclas J, Sinagra A, Dictar M, et al. Chagas disease in bone marrow transplantation: An approach to preemptive therapy. Bone Marrow Transplant. 2005;36(2):123-129.
Altclas J, Sinagra A, Jaimovich G, et al. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole. Transpl Infect Dis. 1999;1(2):135-137.
Angheben A, Giaconi E. Reactivation of Chagas disease after a bone marrow transplant in Italy: First case report. Blood Transfus. 2012;10(4):542-544.
Guiang KMU, Cantey P, Montgomery SP, et al. Reactivation of Chagas disease in a bone marrow transplant patient: Case report and review of screening and management. Transpl Infect Dis. 2013;15(6):E264-E267.
Dictar M, Sinagra A, Verón M, et al. Recipients and donors of bone marrow transplants suffering from Chagas’ disease: Management and preemptive therapy of parasitemia. Bone Marrow Transplant. 1998;21(4):391-393.
Chalela CM, Peña AM, Roa AM, et al. Reactivation of Chagas disease after autologous hematopoietic stem cell transplantation. Rev Soc Bras Med Trop, 2021;54:e20200143.
Requejo AA, Saá GEG, Endara AA, Jaimovich GG. 241.4: Chagas Disease (CD) after hematopoietic stem cells transplantation (HSCT). Incidence, diagnosis and management. Transplantation. 2022;106(9S):S127.
Fabiani S, Fortunato S, Petrini M, Bruschi F, Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections. Transpl Infect Dis. 2017;19(2).
Bern C. Chagas disease in the immunosuppressed host. Curr Opin Infect Dis. 2012;25(4):450-457.
Carvalho NB, De Freitas VT, Bezerra RC, et al. Aplastic anemia and Chagas Disease: T. cruzi Parasitemia Monitoring by quantitative PCR and preemptive antiparasitic therapy. Tropical Med Infect Dis. 2022;7(10):268.
Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, Boer MD Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671.
Sirvent-Von Bueltzingsloewen A, Marty P, Rosenthal E, Delaunay P, Allieri-Rosenthal A, Gratecos N, Cassuto JP Visceral leishmaniasis: A new opportunistic infection in hematopoietic stem-cell-transplanted patients. Bone Marrow Transplant. 2004;33(6):667-668.
Komitopoulou A, Tzenou T, Baltadakis J, Apostolidis J, Karakasis D, Harhalakis N. Is leishmaniasis an “unusual suspect” of infection in allogeneic transplantation? Transpl Infect Dis. 2014;16(6):1012-1018.
Radujkovic A, Hundemer M, Eisenbach C, et al. Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant. Leukemia Lymphoma. 2014;55(12):2967-2969.
Martínez-Losada C, Martin C, Cuenca T, Torres A, Duodenal leishmaniasis after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48(4):614-615.
Agteresch HJ, Van 'T Veer MB, Cornelissen JJ, Sluiters JF. Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;40(4):391-393.
Dantas Brito M, Campilho F, Branca R, et al. Visceral Leishmaniasis: A differential diagnosis to remember after bone marrow transplantation. Case Rep Hematol. 2014;2014:1-2.
Drexler B, Holbro A. Unexpected bone marrow finding in a patient with pancytopenia after hematopoietic stem cell transplantation. Blood. 2014;124(5):678.
Bautista G, Ramos A, Gil S. Visceral leishmaniasis in hematopoietic stem cell transplantation. Transpl Int. 2012;25(7):e83-e85.
Clemente WT, Mourão PHO. Leishmaniasis in transplant candidates and recipients: diagnosis and management. in: Morris MI, Kotton CN, Wolfe C, eds. Emerging Transplant Infections: Clinical Challenges and Implications. Springer International Publishing; 2020:1-31.
Gajurel K, Dhakal R, Deresinski S. Leishmaniasis in solid organ and hematopoietic stem cell transplant recipients. Clin Transplant. 2017;31(1).
Tatarelli P, Fornaro G, Del Bono V, et al. Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature. J Infect Chemother. 2018;24(12):990-994.
Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M. Leishmaniasis among organ transplant recipients. Lancet Infect Dis. 2008;8(3):191-199.